Lymphoma

Showing 1 - 25 of 1,622

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PET/CT Vs BMB in Exclusion of BM Infiltration for Initial

Not yet recruiting
  • Lymphoma
  • positron emission tomography for exclusion of bone marrow infiltration in lymphoma
  • (no location specified)
Sep 30, 2022

Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

Not yet recruiting
  • Pediatric Cancer
  • +11 more
  • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
  • Milwaukee, Wisconsin
    Children's Wisconsin
Sep 14, 2022

Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

Recruiting
  • Lymphoma
  • +4 more
  • Pharmacokinetics
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 12, 2022

Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • Hangzhou, Zhejiang, China
  • +6 more
Sep 7, 2022

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +48 more
Aug 19, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

Recruiting
  • Lymphoma, Non-Hodgkin
  • +6 more
  • CB-010
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Aug 19, 2022

Lymphoma Trial in Beijing (Plerixafor,G-CSF)

Not yet recruiting
  • Lymphoma
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Aug 19, 2022

Metastatic Cancer, Locally Advanced Cancer, Thoracic Cancer Trial in New York (Weekly 45 minute Sessions)

Active, not recruiting
  • Metastatic Cancer
  • +5 more
  • Weekly 45 minute Sessions
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 19, 2022

Lymphoma Trial in Worldwide (Glofitamab, Tocilizumab, Doxorubicin)

Recruiting
  • Lymphoma
  • Duarte, California
  • +13 more
Aug 18, 2022

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Lymphoma Trial in Toulouse (Questionnaires/Scales, Human blood sample)

Active, not recruiting
  • Lymphoma
  • Questionnaires/Scales
  • Human blood sample
  • Toulouse, France
    Institut Universitaire du Cancer de Toulouse CHU de Toulouse
Aug 17, 2022

Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)

Recruiting
  • Melanoma
  • +4 more
  • Pembrolizumab
  • Aurora, Colorado
  • +17 more
Aug 17, 2022

Cognitive Aftereffects of Neurotoxicity in Children and Young

Not yet recruiting
  • Lymphoma
  • Leukemia
    • Los Angeles, California
    • +2 more
    Aug 17, 2022

    A Study of People With CD30 Positive Lymphoma in China

    Not yet recruiting
    • Lymphoma
      • (no location specified)
      Aug 17, 2022

      Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

      Not yet recruiting
      • Lymphoma
      • +4 more
      • Vysis LSI MYC Break Apart Rearrangement Probe Kit
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      Lymphoma Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (PNEUMOVAX 23, Fluarix, FluLaval)

      Recruiting
      • Lymphoma
      • PNEUMOVAX 23
      • +9 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +7 more
      • Duarte, California
      • +26 more
      Aug 11, 2022

      Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

      Recruiting
      • Solid Tumor Malignancy
      • +4 more
      • mrna 1273 injection
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 12, 2022

      Physical Activity in Cancer Patients Assessed by Questionnaire

      Recruiting
      • Lymphoma
      • +2 more
      • No intervention - observational study only
      • Greifswald, Germany
        University Medicine Greifswald
      Aug 11, 2022

      Lymphoma, Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab, Brexucabtagene Autoleucel)

      Not yet recruiting
      • Lymphoma
      • Mantle Cell Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 10, 2022

      Oral Mucositis, Lymphoma, Multiple Myeloma Trial in Seoul (MIT-001, normal saline)

      Recruiting
      • Oral Mucositis
      • +3 more
      • Seoul, Korea, Republic of
      • +1 more
      Aug 9, 2022

      Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

      Not yet recruiting
      • Lymphoma
      • +2 more
      • Web Application
      • San Francisco, California
        University of California, San Francisco
      Aug 9, 2022